Latest Regulatory News

Everlast Minerals Ltd has issued a Replacement Prospectus for a $4-6 million ASX IPO to fund its mineral sands projects in Bangladesh, focusing on advancing the Gaibandha project towards commercial production.

Woolworths Group Limited has updated its dividend details, confirming a fully franked 45 cent per share payout for the first half of FY25 and setting the Dividend Reinvestment Plan price at $27.78.

Advance Metals Limited explains its recent share price jump and trading volume spike as driven by investor relations efforts and an upcoming assay results announcement from its Myrtleford Project.

The Supreme Court of New South Wales has approved Shenghe Resources’ acquisition scheme for Peak Rare Earths, setting the stage for a significant ownership change and share suspension on the ASX.

Focus Minerals Ltd has responded to an ASX price query following a significant intra-day share price jump, confirming no undisclosed information and compliance with listing rules.

Echo IQ has completed its presentation to the CPT Editorial Panel for a Category III CPT code for EchoSolv AS, with a decision expected from the American Medical Association in the coming weeks. Meanwhile, the company is advancing US deployments and FDA clearance efforts.

An application to the Takeovers Panel challenges Duxton Farms’ recent merger and share placement, alleging undisclosed associations and potential breaches of takeover laws by major shareholders.

Following its recent sale transaction, MPR Australia Limited announces significant board resignations alongside continued leadership under CEO Nathan Wise, signaling a strategic transition phase.

Elanor Investors Group is set to reclaim over 12 million stapled securities from Challenger’s Fidante subsidiary as part of unwinding their strategic partnership, reshaping ownership stakes and signaling a new chapter for the funds manager.

Bass Oil Limited reported a 20% increase in August sales revenue alongside a 3.5% rise in daily production, while progressing regulatory approval for its strategic Vanessa gas field acquisition.

Island Pharmaceuticals has won a crucial FDA Type C meeting to discuss fast-tracking its antiviral Galidesivir for Marburg virus treatment, with written feedback expected by November.

Swift Networks secures a landmark Master Services Agreement with Opal HealthCare to deploy its innovative Swift TV platform across multiple aged care communities, marking a significant step in aged care technology integration.